Fundraising Fox

Bio2 Technologies

Woburn, US · Founded 2018 · Delaware corporation

Biotech

Founders & leadership

PN
Paul Nichols, Jr.Executive
AO
Arthur O'DeaExecutive

Board

RI
Richard IntraterBoard director
DG
Donald GrimmBoard director
CB
Cheryl BlanchardBoard director
GJ
Gary JacobsBoard director
DL
Debora LaBuddeBoard director
DK
Douglas KohrsBoard director

Reported raises · per SEC filings

Form D private placements

$13.3M disclosed across 5 rounds · 2016–2021

▶$900KraisedDec 2021 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ted BirdDirector
  • Arpesh MehtaDirector
  • Art O/DeaExecutive Officer
  • Thomas A. AfzalExecutive Officer, Director
  • Gary JacobsDirector
Offering amount
$1.8M
Amount sold
$900K
Minimum investment
$1
First sale
Nov 2021
Incorporated
Corporation, De, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.2MraisedDec 2020 · 24 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas A. AfzalExecutive Officer
  • Ted BirdDirector
  • Arpesh MehtaDirector
  • David GillDirector
  • Gary JacobsDirector
  • Paul NicholsDirector
Offering amount
$4M
Amount sold
$3.2M
First sale
Dec 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.3MraisedSep 2019 · 27 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul K. Nichols, Jr.Executive Officer, Director
  • Pieter WoltersDirector
  • Douglas KohrsDirector
  • Gary JacobsDirector
Offering amount
$6.5M
Amount sold
$4.3M
Finders' fees
$260K
Placement agents
Mirus Securities, Inc.
First sale
Aug 2019
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.5MraisedSep 2018 · 26 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul K. Nichols, Jr.Executive Officer, Director
  • Douglas KohrsDirector
  • Gary JacobsDirector
  • Cheryl BlanchardDirector
Offering amount
$4.5M
Amount sold
$4.5M
Finders' fees
$240K
Placement agents
Mirus Securities, Inc.
First sale
Aug 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$356.2KraisedSep 2016 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard IntraterDirector
  • Donald GrimmDirector
  • Cheryl BlanchardDirector
  • Gary JacobsDirector
  • Debora LaBuddeDirector
  • Paul Nichols, Jr.Executive Officer, Director
  • Arthur O'DeaExecutive Officer
  • Douglas KohrsDirector
Offering amount
$2M
Amount sold
$356.2K
First sale
Aug 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Bio2 Technologies raised?
Bio2 Technologies has disclosed $13.3M raised across 5 rounds.
Where is Bio2 Technologies headquartered?
Bio2 Technologies is headquartered in Woburn, US.